Introducing 53Biologics’ New GMP Production Line for Biologics

Introducing 53Biologics’ New GMP Production Line for Biologics

53Biologics, a leading Spanish CDMO specializing in biologics production and cGMP manufacturing, is pleased to announce the opening of a new GMP production line for microbial-based therapeutics. The new production line boasts a 2000L reactor.

Boecillo, Spain – This new addition to 53Biologics's manufacturing facility allow them to
meet the growing demand for microbial-based products and serve more clients across
the globe. In addition to the 2000L reactor, the new GMP production line is equipped
with a range of single-use downstream equipment, including chromatography systems,
filtration units, and purification systems. These advanced technologies allow us to
produce high-quality, pure biologics products with a high yield and efficiency.

"We are thrilled to add this new GMP manufacturing line to our existing capabilities for
biologics production," said Pablo Gutierrez, CEO of 53Biologics. "This investment not only
expands our capacity to 2000L but also enhances our ability to deliver high-quality
services to our clients. The new plant enables us to scale-up production for larger
batches, which can result in cost savings for our clients. It also enables us to better meet
the growing demand for microbial-based biotherapeutics, which is increasingly
becoming the focus of the pharmaceutical industry."

The installation of the new fermenter marks another milestone in 53Biologics's ongoing
efforts to expand its service offerings and meet the evolving needs of the biologics
industry. With this new addition, 53Biologics is well-positioned to serve a wide range of
clients, including those in the pharmaceutical, biotech and academic sectors.

"We are excited about the new opportunities this new plant brings to our company and
our clients," said Francisco Reyes, Business Development Manager of 53Biologics. "We
remain committed to delivering superior quality services to our clients, and this new
2000L fermenter will help us achieve that goal."

About 53Biologics:

53Biologics is a CDMO with extensive experience in biologics production. The company
offers a range of services for the biopharma industry, including process development,
clinical manufacturing and analytical testing, to support every step up to
commercialization of biotherapeutics.

For more information on the company and its services, please visit 53Biologics.com or
contact Patricia De La Madrid, Marketing & Business Development Manager at
53Biologics at pdelamadrid@53biologics.com